Commercialized diagnostic technologies to combat SARS-CoV2: Advantages and disadvantages

Title
Commercialized diagnostic technologies to combat SARS-CoV2: Advantages and disadvantages
Authors
Keywords
Covid-19, SARS-CoV-2, In vitro diagnosis (IVD), Reverse transcriptase polymerase chain reaction (RT-PCR), Point of care (POC), Lateral flow immunoassay
Journal
TALANTA
Volume 225, Issue -, Pages 121898
Publisher
Elsevier BV
Online
2020-12-04
DOI
10.1016/j.talanta.2020.121898

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now